1. Home
  2. ACDC vs AUPH Comparison

ACDC vs AUPH Comparison

Compare ACDC & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProFrac Holding Corp.

ACDC

ProFrac Holding Corp.

HOLD

Current Price

$6.84

Market Cap

1.1B

Sector

Energy

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.98

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACDC
AUPH
Founded
2014
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
2.0B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
ACDC
AUPH
Price
$6.84
$15.98
Analyst Decision
Sell
Buy
Analyst Count
2
4
Target Price
$5.50
$17.25
AVG Volume (30 Days)
1.4M
1.3M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5075.00
EPS
N/A
0.25
Revenue
$1,941,800,000.00
$283,055,000.00
Revenue This Year
N/A
$17.54
Revenue Next Year
$11.50
$15.74
P/E Ratio
N/A
$66.00
Revenue Growth
N/A
20.38
52 Week Low
$3.08
$7.29
52 Week High
$10.70
$16.88

Technical Indicators

Market Signals
Indicator
ACDC
AUPH
Relative Strength Index (RSI) 48.83 54.94
Support Level $5.82 $14.53
Resistance Level $7.85 $16.29
Average True Range (ATR) 0.61 0.54
MACD 0.00 0.07
Stochastic Oscillator 44.16 60.52

Price Performance

Historical Comparison
ACDC
AUPH

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is a technology-focused, vertically integrated energy services company providing hydraulic fracturing, proppant production, completion services, and related products, including distributed power generation, to upstream oil and natural gas companies in the United States. The Company operates through four segments: Stimulation Services, Proppant Production, Manufacturing, and Flotek. The Stimulation Services segment, which generates maximum revenue, provides hydraulic fracturing services using mobile units and auxiliary equipment. The Proppant Production segment supplies proppant, the Manufacturing segment sells engineered products such as pumps, valves, and piping, and Flotek is a chemistry and data technology company serving the E&P industry.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: